Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
Rhea-AI Summary
Maravai LifeSciences (MRVI) will release its second quarter 2022 financial results post-market on August 4, 2022. A conference call will follow at 2:00 p.m. PT/5:00 p.m. ET, accessible via phone or webcast. The company specializes in life science products critical for drug therapy and vaccine development, supporting biotechnology and pharmaceutical sectors globally.
Positive
- None.
Negative
- None.
News Market Reaction – MRVI
In the trading session that priced this news, MRVI gained 8.33%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2022 financial and operating results after the market closes on Thursday, August 4, 2022, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (877) 407-0890 or (201) 389-0918 and reference Maravai LifeSciences. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
